Coccidioidomycosis screening: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
m (Bot: Removing from Primary care)
 
(One intermediate revision by one other user not shown)
Line 11: Line 11:


{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Fungal diseases]]
[[Category:Fungal diseases]]
[[Category:Biological weapons]]
[[Category:Biological weapons]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Disease]]
[[Category:Disease]]
{{WH}}
[[Category:Emergency medicine]]
{{WS}}
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 21:00, 29 July 2020

Coccidioidomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Coccidioides immitis
Coccidioides posadasii

Differentiating Coccidioidomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Coccidioidomycosis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coccidioidomycosis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coccidioidomycosis screening

CDC on Coccidioidomycosis screening

Coccidioidomycosis screening in the news

Blogs on Coccidioidomycosis screening

Directions to Hospitals Treating Coccidioidomycosis

Risk calculators and risk factors for Coccidioidomycosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]

Overview

It is important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.

Screening

Coccidioidomycosis is often mistaken for community acquired pneumonia(CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.[1]

References

  1. Chang, DC.; Anderson, S.; Wannemuehler, K.; Engelthaler, DM.; Erhart, L.; Sunenshine, RH.; Burwell, LA.; Park, BJ. "Testing for coccidioidomycosis among patients with community-acquired pneumonia". Emerg Infect Dis. 14 (7): 1053–9. doi:10.3201/eid1407.070832. PMID 18598625.

Template:WH Template:WS